Patent · US Active

Formulations containing nalbuphine and uses thereof

US10441585B2 · kind B2 · utility

0Cited by

3References

10Claims

0Family size

Assignee

DEBREGEAS ET ASSOCIES PHARMA · FR

Inventors

Christophe Lebon · Rouvres, FR
Pascal Suplie · Montaure, FR
David Olivier Paul · Dreux, FR

Key dates

Filing date	Jun 1, 2016
Grant date	Oct 15, 2019
Priority date	—
Expiry date	Jun 5, 2036

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K9/5078
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Immediate release, oral, pharmaceutical formulation comprising nalbuphine or a pharmaceutically acceptable salt thereof, and at least one hydrophilic granulation carrier, one hydrophilic binder and one lubricant.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.